Company Filing History:
Years Active: 2006-2009
Title: Wayne Minobe: Innovator in Myocardial Failure Treatment
Introduction
Wayne Minobe is a prominent inventor based in Golden, CO (US), known for his significant contributions to the field of cardiac health. He holds 2 patents that focus on the diagnosis and treatment of myocardial failure, showcasing his dedication to advancing medical science.
Latest Patents
Minobe's latest patents include innovative methods for diagnosing and treating myocardial failure in humans. The first patent provides a method that involves administering an effective amount of a transgene encoding α-MHC, which directly increases the quantity of α-MHC in the myocardial tissue of the heart. The second patent outlines methods for diagnosing myocardial failure by obtaining a sample of myocardial tissue from a ventricle of the heart. This method quantifies the expression levels of α-myosin heavy chain and β-myosin heavy chain, comparing them to normal human ventricular myocardial tissues. Additionally, it includes therapeutic interventions based on altering the expression of specific genes related to thyroid hormone receptors.
Career Highlights
Wayne Minobe is affiliated with the University of Colorado, where he continues to contribute to research and innovation in cardiac health. His work has the potential to significantly impact the treatment of heart conditions, improving patient outcomes.
Collaborations
Minobe collaborates with esteemed colleagues such as Michael R. Bristow and Leslie A. Leinwand, further enhancing the research efforts in his field.
Conclusion
Wayne Minobe's innovative work in the diagnosis and treatment of myocardial failure exemplifies his commitment to improving cardiac health. His patents reflect a deep understanding of the complexities of heart function and offer promising avenues for future research and therapeutic interventions.